TAS2R expression, and particularly the TAS2R38 variants, has demonstrated prognostic value for sinonasal diseases, dental disease, otitis media, head and neck cancer, and thyroid cancer and dysfunction. This evidence concerns the gene TAS2R38 and thyroid cancer.